Nocturnal Hypertension Predictor of progression of Diastolic Dysfunction among Diabetes patients Without HF: Study Aditi8 March 2024 8:00 PM ISTJapan: Researchers have found in a new study that nocturnal hypertension may predict the progression of left ventricular (LV) diastolic dysfunction...
Hypochloremia may increase in-hospital mortality and hospital stay in critically ill patients with HF Dr. Shravani Dali25 Dec 2023 10:15 AM ISTHypochloremia may increase in-hospital mortality and hospital stay in critically ill patients with HF suggests a new study published in the...
Empagliflozin reduces HF hospitalization and CV death regardless of baseline diuretic doses Dr. Shravani Dali18 Sept 2023 12:00 PM ISTEmpagliflozin reduces HF hospitalization and CV death regardless of baseline diuretic doses suggests a new study published in the JACC: Heart...
Long-term exposure to road traffic noise associated with higher risk of incident HF Dr. Shravani Dali16 July 2023 8:30 PM ISTLong-term exposure to road traffic noise is associated with a higher risk of incident HF suggests a new study published in the JACC: Heart...
Higher Mortality Patterns recorded with Central Sleep Apnea compared to Obstructive Sleep Apnea Aditi2 April 2023 8:00 PM ISTUnited States: A study published in the Annals of American Thoracic Society has concluded that the highest predictors of mortality in central sleep...
Hypertension patients with shortened fingers and genetic mutation immune to development of LVH and HF Dr. Kamal Kant Kohli21 Oct 2022 8:00 PM ISTBerlin: Researchers at the Max Delbrück Center (MDC) in Berlin have found in a new study that Hypertension patients with a hereditary condition...
Heatwave and hot temperatures linked with weight loss and worsening of condition of HF patients Dr. Kamal Kant Kohli24 Sept 2022 5:45 AM ISTResearchers have found in a nationwide study in France that Heatwave and hot temperatures were closely linked with weight loss and worsening of...
SGLT2 inhibitors foundational therapy in all HF patients regardless of EF: Pooled analysis of DAPA-HF and DELIVER Dr. Kamal Kant Kohli9 Sept 2022 8:00 PM ISTPrevious studies have shown that the SGLT2 inhibitor dapagliflozin reduces cardiovascular mortality and morbidity in patients with diabetes, chronic...
SGLT2 inhibitors useful for HF patients with mildly reduced and preserved ejection fraction: Deliver Trial Dr. Kamal Kant Kohli7 Sept 2022 11:00 AM ISTPrevious studies have shown that the SGLT2 inhibitor dapagliflozin reduces cardiovascular mortality and morbidity in patients with diabetes, chronic...
Replace ACE inhibitors with sacubitril/valsartan once symptomatic HF develops in MI: insight from Paradise MI Dr. Kamal Kant Kohli30 Aug 2022 11:00 AM ISTPost hoc analysis of Paradise MI Trial has provided new insights on sacubitril/valsartan in myocardial infarction in a session in a Hot Line session...
COVID mRNA vaccines reduce risk of complications and death among patients with heart failure Dr. Kamal Kant Kohli23 Aug 2022 7:30 AM ISTPatients with heart failure are at increased risk of hospitalisation mechanical ventilation and death due to COVID-19.It is known that Vaccination...
Too much restriction of salt may worsen outcomes in patients with HF with preserved ejection fraction Dr. Kamal Kant Kohli19 July 2022 11:15 AM ISTSalt restriction is frequently recommended in heart failure guidelines, but the optimal restriction range (from less than 1.5 g to less than 3 g...
